Summary
The United States District Court for the District of Delaware addresses Whatfix's motion to dismiss a patent infringement action involving U.S. Patent Nos. 8,087,007 and 9,285,948. The court holds that claim 1 of the '007 patent is directed to patent-ineligible subject matter under 35 U.S.C. § 101, while claim 1 of the '948 patent survives the eligibility challenge, and concludes that the plaintiffs plausibly alleged willful infringement.
Holdings
- Claim 1 of the 007 patent is patent-ineligible because it is directed to the abstract idea of enabling a user to directly modify graphical user interfaces in a simulation file without affecting the underlying software and lacks an inventive concept.
- Claim 1 of the 948 patent is patent-eligible because it is directed to a specific technological solution using hierarchically linked screen templates to permit modification of a common interface element across multiple display screens, rather than to the abstract organization or presentation of information.
- Assima plausibly pleaded willful infringement because its pre-suit notice letter identified the asserted patents, identified Whatfix's allegedly infringing Mirror product, and asserted that the product infringed those patents.
- The complaint asserted infringement of claims beyond claim 1 of the 007 patent; therefore, dismissal of claim 1 did not require dismissal of the 007 patent or its remaining claims.
- Assima was granted leave to amend.
Questions Presented
- Whether claim 1 of U.S. Patent No. 8,087,007 is directed to an abstract idea and lacks an inventive concept under the Alice patent-eligibility framework.
- Whether claim 1 of U.S. Patent No. 9,285,948 is directed to an abstract idea under 35 U.S.C. § 101.
- Whether Assima plausibly pleaded willful infringement based on its complaint and pre-suit notice letter.
- Whether the complaint asserted infringement of claims beyond claim 1 of the 007 patent.
- Whether Assima should be granted leave to amend.
Disposition
other
Cases Cited (35)
- Alice Corp. Pty. v. CLS Bank Int'l, 573 U.S. 208 (2014)(followed)
- Association for Molecular Pathology v. Myriad Genetics, Inc., Association for Molecular Pathology v. Myriad Genetics, Inc., 569 U.S. 576 (2013)(followed)
- Mayo Collaborative Services v. Prometheus Laboratories, Inc., 566 U.S. 66 (2012)(followed)
- SAP America, Inc. v. InvestPic, LLC, 898 F.3d 1161, 1166 (Fed. Cir. 2018)(followed)
- Affinity Labs of Texas, LLC v. DIRECTV, LLC, 838 F.3d 1253, 1257 (Fed. Cir. 2016)(followed)
- Enfish, LLC v. Microsoft Corp., 822 F.3d 1327, 1334 (Fed. Cir. 2016)(followed)
- ChargePoint, Inc. v. SemaConnect, Inc., 920 F.3d 759, 766 (Fed. Cir. 2019)(followed)
- TecSec, Inc. v. Adobe Inc., 978 F.3d 1278, 1292 (Fed. Cir. 2020)(followed)
- Trinity Info Media, LLC v. Covalent, Inc., 72 F.4th 1355, 1362 (Fed. Cir. 2023)(followed)
- Aon Re, Inc. v. Zesty.Ai, Inc., 791 F. Supp. 3d 531, 536-37 (D. Del. 2025)(followed)
Showing top 10 of 35.
Cited In (0)
No citing cases on record yet.
Court Document
Open PDFLoading document…